Most of the conversation about Wegovy is about starting it. Far less is said about stopping — which is a problem, because that's where the outcome is actually decided.
There are lots of reasons, and none of them are failures. Cost is a common one. So is reaching a goal weight, side effects, supply problems, coming to the end of a prescribed course, or simply not wanting to be on a medication indefinitely.
Whatever the reason, the same transition follows, and the same preparation helps.
Wegovy is semaglutide, a GLP-1 receptor agonist. It acts on appetite signalling — slowing gastric emptying and influencing how the brain regulates hunger and satiety. As it clears from your system over the weeks after stopping, those effects fade.
In practice, people describe:
Treating the medication as the intervention, and everything else as optional.
It's an entirely understandable mistake. Wegovy works well, and while it's working, the eating patterns that come naturally feel sustainable. There's no obvious reason to build anything more deliberate — appetite is quiet, the pressure is off, and it's working.
The habits that keep weight stable are usually built while appetite is suppressed and the pressure is off. That window is the opportunity, and most people go through it without any structure at all.
Then the medication stops, and those untested patterns have to hold under real appetite for the first time. That's the moment things unravel — not because of any lapse, but because nothing underneath was ever built to bear weight.
Protein at every meal, meals of enough volume to produce genuine fullness, and consistent timing. The goal is for physical satiety to take over part of the job the medication was doing. Practise it while still on medication, so it's established before it's needed.
Weight lost on semaglutide includes lean mass, not just fat. Protecting muscle through the transition protects metabolic rate — which is a large part of what determines how hard maintenance feels a year later.
Both are powerful appetite variables and both get treated as separate issues. They aren't. A run of bad sleep can make food noise substantially louder on its own.
The transition period is exactly when most support ends — the prescription finishes and the contact stops. That is precisely backwards. This is when structure matters most.
This is a clinical question, not a coaching one, and the honest answer is that it depends on your circumstances, your dose and your prescriber's judgement. Ask them — do not decide based on an article, including this one.
What we can say is that whatever the taper schedule, the behavioural work is the same, and starting it earlier makes it easier.
Perdura is a coaching programme, not a medical service. This guide is general information and not medical advice.
Never stop, start or change the dose of Wegovy or any other medication based on something you have read here. Those decisions belong with your prescriber, and we will always ask you to keep them involved.
Wegovy is a prescription-only medicine. For clinical information, see the NHS page on semaglutide.
Perdura is a structured twelve-week programme built specifically for this window — rebuilding appetite regulation so it holds once the medication stops. A discovery call is a short conversation to see whether it's the right fit.